We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Novel Magnet Compression Anastomosis Technology Ensures Fewer Complications, Bleeds or Leaks

By HospiMedica International staff writers
Posted on 09 Sep 2024
Print article
Image: The MagDI System for side-to-side duodeno-ileal anastomosis has been granted FDA De Novo marketing authorization (Photo courtesy of GT Metabolic Solution)
Image: The MagDI System for side-to-side duodeno-ileal anastomosis has been granted FDA De Novo marketing authorization (Photo courtesy of GT Metabolic Solution)

Traditional anastomotic devices like staples or sutures can be challenging to apply in tight spaces during minimally invasive surgeries and may harm bowel tissue by cutting or piercing it, leaving foreign material behind. Now, an incisionless, sutureless, staple-free technique based on a proprietary magnetic compression anastomosis technology is set to revolutionize how surgeons achieve anastomosis.

GT Metabolic Solutions (St. Michael, MN, USA) is at the forefront of pioneering this magnetic compression anastomosis technology for advanced minimally invasive procedures. This technology is designed to eliminate the need for bowel incisions, minimize technical variability by the user during procedures, and allow natural excretion from the body. The technique employs magnets to achieve anastomosis without leaving foreign materials behind, thus promoting the natural tissue healing process. To date, seven peer-reviewed studies have been conducted, including a recent multi-center clinical trial with 43 patients that reported no anastomotic leaks, bleeds, or obstructions in duodeno-ileal side-to-side anastomosis during bariatric and metabolic surgeries.

Going forward, the researchers plan to conduct studies to broaden the improvements in patient outcomes and extend the reach of this minimally invasive anastomotic technique to more patients. The company’s MagDI System for side-to-side duodeno-ileal anastomosis has now received De Novo marketing authorization from the U.S. Food and Drug Administration (FDA). In addition, the company has developed a magnetic compression solution known as delayed anastomosis technology (DAT) in collaboration with leading global experts. This technology provides surgeons with a consistent method to create anastomoses while aiming to reduce complications like leaks and bleeds in complex procedures. This solution simplifies the surgical approach to anastomosis, enables use in procedure staging, and is completely reversible.

"Creating a secure anastomosis free of complications bleeds or leaks is the goal of any minimally invasive surgical approach," said Michel Gagner, MD, and Co-Founder of GT Metabolic. "Magnetic compression anastomosis is designed to allow for more consistent tissue alignment, central necrosis, and circumferential healing while leaving no foreign materials behind to impede the natural tissue healing process."

"Obtaining Medical Device De Novo Classification to market our platform in just four years following the company's inception is incredible," added Thierry Thaure, CEO, and Co-Founder, GT Metabolic. "The MagDI System offers the concept, for the first time, to democratize the surgical approach to anastomosis, enabling surgeons to potentially achieve a more consistent outcome in a less invasive and potentially less expensive solution. We are looking forward to worldwide launch of our incisionless anastomosis system later this year."

Related Links:
GT Metabolic Solutions

Gold Member
12-Channel ECG
CM1200B
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Infusion Stand Rotatable Clamp
10-400 Infusion Stand Rotatable Clamp
New
Portable Color Doppler Ultrasound Scanner
DCU10

Print article
Radcal

Channels

Critical Care

view channel
Image: The Biointegrated Implantable Systems for Cell-based Sensing and Therapy technology can be used to treat various diseases (Photo courtesy of 123RF)

Implantable Cell-Based Bioelectronic Devices to Enable Patient-Specific Treatment and Disease Monitoring

Researchers are advancing the development of implantable, cell-based bioelectronic devices designed to provide personalized therapy and monitor disease conditions such as hypo- and hyperthyroidism in real-time.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.